GE Healthcare Life Sciences is increasing the annual production capacity of powdered cell culture media by tenfold in its facility in Pasching, Austria.

Two additional licenses granted; upfront payment of US$18 million; total potential transaction value of up to US$484.7 million.

Antibodies Used to Support Research into the Treatment of Ulcerative Colitis and Crohn’s Disease.

Complete and easy-to-use LC-MS-based solution for biotherapeutics characterization and quality testing.

Distributors will supply Chirascan circular dichroism spectrometers and SX stopped-flow spectrometers to Italy, Portugal and Spain.

Agendia, Inc., a world leader in personalized medicine and molecular cancer diagnostics, announce that Unicancer, a hospital group entirely devoted to fighting cancer, has selected the MammaPrint® Breast Cancer Risk of Recurrence test and BluePrint® Molecular Subtyping test for use in its 18 French Comprehensive Cancer Centers (FCCC).

Biotage is pleased to announce the launch of a new unique UV Monitor Kit which can be easily added to Biotage® Flash 150 and Biotage® Flash 400 systems in pharmaceutical development or manufacturing environments.

StarBright Blue 520 Fluorescent Secondary Antibodies offer best sensitivity among fluorescent dye–labeled secondary antibodies that emit in the green channel.

Phenomenex Inc. introduces Zebron™ ZB-624PLUS™ GC columns for volatile organic compound analysis.

The immunoassay is the market’s first validated high-performance multiplex screening panel.